$XLK Headlines S&P 500 back for another crack at the

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$XLK Headlines

S&P 500 back for another crack at the January low 10:18 a.m. Jan. 16, 2015 - Michael Ashbaugh
Charting the bull-bear debate 11:16 a.m. Jan. 15, 2015 - Michael Ashbaugh
U.S. benchmarks venture below major support 9:42 a.m. Jan. 14, 2015 - Michael Ashbaugh
Growth speculators should take note of biotechs 3:11 p.m. Jan. 9, 2015 - The Trading Deck
Market technicals bend, but don’t break 11:08 a.m. Jan. 9, 2015 - Michael Ashbaugh
S&P 500 violates major support 11:19 a.m. Jan. 7, 2015 - Michael Ashbaugh
S&P 500’s technical backdrop takes tenuous turn 11:59 a.m. Jan. 6, 2015 - Michael Ashbaugh
S&P 500’s technical backdrop takes tenuous turn 11:36 a.m. Jan. 6, 2015 - Michael Ashbaugh
11 ETFs that could make your new year 1:32 p.m. Dec. 22, 2014 - Victor Reklaitis
5 high-yield, high-tech stocks for 2015 6:30 a.m. Dec. 18, 2014 - Jeff Reeves
What to expect from Oracle’s earnings 3:15 p.m. Dec. 17, 2014 - Tomi Kilgore
S&P, Dow venture under major support 11:46 a.m. Dec. 17, 2014 - Michael Ashbaugh
Volatility spike signals a market low may be in 1:01 p.m. Dec. 16, 2014 - Michael Ashbaugh
Volatility spike signals a market low may be in 12:31 p.m. Dec. 16, 2014 - Michael Ashbaugh
Market downturn reaches line in the sand 12:16 p.m. Dec. 15, 2014 - Michael Ashbaugh
S&P 500 spikes from major support 11:32 a.m. Dec. 11, 2014 - Michael Ashbaugh
Charting an oil-induced market whipsaw 11:30 a.m. Dec. 1, 2014 - Michael Ashbaugh
Dow takes flight, S&P scratches out record high 11:01 a.m. Nov. 6, 2014 - Michael Ashbaugh
U.S. markets break out, confirm primary uptrend 11:12 a.m. Nov. 3, 2014 - Michael Ashbaugh
Charting a ‘flat’ October performance 11:34 a.m. Oct. 29, 2014 - Michael Ashbaugh


Anti-Hacker Fund Debuts 3:05 a.m. Jan. 17, 2015 - Barrons.com
S&P 500 Suffers Fifth Straight Day of Losses After Volatile Session 4:10 p.m. Jan. 15, 2015 - TheStreet.com
Stocks Extend Losses as Banks and Tech Stocks Get Squeezed 2:30 p.m. Jan. 15, 2015 - TheStreet.com
Sector Performance Since Tuesday's Highs 2:11 a.m. Jan. 15, 2015 - Seeking Alpha
Smartphones At A Tipping Point In China 3:56 p.m. Jan. 14, 2015 - Seeking Alpha
Diversifying By Sectors 5:47 a.m. Jan. 14, 2015 - Seeking Alpha
Technology ETF: XLK No. 3 Select Sector SPDR In 2014 3:04 p.m. Jan. 13, 2015 - Seeking Alpha
Why I'm Not Closing My Position In Columbia Seligman Premium Tech Fund 12:34 p.m. Jan. 13, 2015 - Seeking Alpha
Tech.pinions CES 2015 Podcast 4:16 a.m. Jan. 11, 2015 - Seeking Alpha
Get Back in the Market and Buy These 3 Sectors for a ‘Steady’ U.S. Economy 5:50 p.m. Jan. 7, 2015 - TheStreet.com
Buy Or Sell This Pullback? 4 Tests To Use 9:46 a.m. Jan. 7, 2015 - Seeking Alpha
More Tech Predictions For 2015 1:32 p.m. Jan. 6, 2015 - Seeking Alpha
Generating Alpha With A 2015 Model Portfolio 11:50 a.m. Jan. 6, 2015 - Seeking Alpha
iShares Plans an Exponential Technology ETF - ETF News And Commentary 8:01 a.m. Jan. 6, 2015 - Zacks.com
Mark Hibben Positions For 2015: Are Tech Giants Vulnerable? 7:07 a.m. Jan. 5, 2015 - Seeking Alpha
Tech.pinions 2015 Predictions (Podcast) 5:18 a.m. Jan. 4, 2015 - Seeking Alpha
Low Risk And Long-Term Success Portfolio Update 2015 7:27 a.m. Jan. 3, 2015 - Seeking Alpha
Five Best ETF Themes For Investors In 2015 5:58 p.m. Jan. 2, 2015 - Investors Business Daily
Wilson's 2015 predictions: Tech stocks, wearables, cybersecurity, Bitcoin 12:08 p.m. Jan. 2, 2015 - Seeking Alpha
2015 Outlook: Pain 4:09 a.m. Dec. 31, 2014 - Seeking Alpha

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 5

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 1

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Thor Equities Sells Amazon Distribution Center for $157M

Updated Category News Views 191

Thor Equities Group Successfully Transacts Major Sale Thor Equities Group, recognized as a leader in urban real estate development and management, has successfully concluded the sale of a significant industrial property. The property, located at 280 Richards Street in Brooklyn, was sold for an impressive $157 million. Details of the 280 Richards Street Property This...

Continue Reading
Exploring the Dynamics of Cloud Object Storage Growth and Demand

Updated Category News Views 169

Understanding Cloud Object Storage Market Evolution The growth of the Cloud Object Storage Market is driven by the exponential rise in unstructured data, increasing adoption of cloud-based services, and the need for scalable, cost-effective storage solutions across industries. Enterprises are rapidly shifting toward hybrid and multi-cloud strategies, boosting demand for...

Continue Reading
Danone's Strategic Acquisition of Kate Farms to Drive Growth

Updated Category News Views 341

Danone Strengthens U.S. Nutrition Offerings with Kate Farms Purchase In a significant move for its health-focused division, Danone has officially finalized the acquisition of a majority stake in Kate Farms. This acquisition positions Danone as a key player in the specialized nutrition market by integrating Kate Farms’ lineup of plant-based, organic nutrition products....

Continue Reading
GSK plc Faces Class Action Over Zantac and Investor Rights

Updated Category News Views 175

Rosen Law Firm Encourages GSK plc Investors to Take Action Rosen Law Firm, renowned for advocating investor rights, is reaching out to shareholders of GSK plc (NYSE: GSK). The firm has been alerted to a class action alleging that GSK misrepresented crucial information regarding its business operations during the class period from February 5, 2020, to August 14, 2022....

Continue Reading
Alibaba's Recent Stock Surge Driven by Cloud Innovation

Updated Category News Views 181

Alibaba Group Holding Ltd's Stock Performance Alibaba Group Holding Ltd (NASDAQ: BABA) recently saw its shares soar by an impressive 18.5% on the Hong Kong Stock Exchange. This spike occurred amid high expectations following a solid quarterly performance from the company’s cloud computing division alongside the launch of a new artificial intelligence chip. Investors are...

Continue Reading